Practice 8 Flashcards
Which of the following are SAFETY monitoring parameters of pravastatin therapy? SATA
- Serum Bilirubin
- GI upset
- Myalgias
- Myopathy
GI upset
Myalgias
Myopathy
Which of the following are SAFETY monitoring parameters of simvastatin therapy? SATA
- Creatine phosphokinase (CPK)
- Lipids
- Serum Bilirubin
- LFTs
Creatine phosphokinase (CPK) LFTs
Which of the following SAFETY monitoring parameters of gemfibrozil therapy? SATA
- Creatine phosphokinase (CPK)
- Lipids
- Serum Bilirubin
- LFTs
Creatine phosphokinase (CPK)
Serum Bilirubin
LFTs
Gemfibrozil is contraindicated in patients who have primary biliary cirrhosis. T/F
True
Rosuvastatin is contraindicated in patients who are pregnant. T/F
True
Lipitor is lipid-regulating agent that decreases LDL and decreases HDL. T/F
False
Lopid is lipid-regulating agent that decreases serum triglycerides and decreases HDL. T/F
False
Atorvastatin is a CYP 3A4 inhibitor. T/F
False
Gemfibrozil is a 2C19 inhibitor. T/F
True
Which of the following medications inhibit CYP 2C9? SATA
- Lipitor
- Lopid
- Crestor
- Tricor
Lopid
Tricor